Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary Baum
Potential Clinical and Immunotherapeutic Utility of Talimogene Laherparepvec for Patients With Melanoma After Disease Progression on Immune Checkpoint Inhibitors and BRAF Inhibitors
Melanoma Research
Dermatology
Cancer Research
Oncology
Related publications
Recurrent Pneumonitis in Patients With Melanoma Treated With Immune Checkpoint Inhibitors
Oncologist
Cancer Research
Medicine
Oncology
Combining Checkpoint Inhibitors and BRAF-targeted Agents Against Metastatic Melanoma
OncoImmunology
Oncology
Allergy
Immunology
Immune Checkpoint Inhibitors in Melanoma: Review and Update
Journal of the Portuguese Society of Dermatology and Venereology
Impact of Clinicopathological Characteristics on Survival in Patients Treated With Immune Checkpoint Inhibitors for Metastatic Melanoma
International Journal of Cancer
Cancer Research
Oncology
Biodistribution, Shedding, and Transmissibility of the Oncolytic Virus Talimogene Laherparepvec in Patients With Melanoma
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Immune Checkpoint Inhibitors and irAEs
Trends in Immunotherapy
Patterns of Failure After Immunotherapy With Checkpoint Inhibitors Predict Durable Progression-Free Survival After Local Therapy for Metastatic Melanoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Cardiotoxicity of Immune Checkpoint Inhibitors in Patients With Lung Cancer
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Immune Checkpoint Inhibitors Therapy in Older Patients (≥ 70 Years) With Metastatic Melanoma: A Multicentre Study
Postepy Dermatologii I Alergologii
Dermatology
Allergy
Immunology
